Yüklüyor......
Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness
CYP2C19 is a principal enzyme involved in the bioactivation of the antiplatelet prodrug clopidogrel and common CYP2C19 loss-of-function alleles are associated with adverse cardiovascular events. To assess the impact of the CYP2C19*17 increased activity allele in the Ashkenazi Jewish (AJ) and Sephard...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3310336/ https://ncbi.nlm.nih.gov/pubmed/21358751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2011.5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|